Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : House Dust Mite Allergen Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
ACARIZAX® Approved in Canada for Treatment of Young Children
Details : Acarizax is a standardised allergen extract from house dust mites Dermatophagoides pteronyssinus and Dermatophagoides farinae. It is being indicated for the treatment of house dust mite allergy.
Product Name : Acarizax
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 07, 2025
Lead Product(s) : House Dust Mite Allergen Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dermatophagoides Farinae Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
FDA Approves ODACTRA for the Treatment of House Dust Mite Allergy in Young Children
Details : Odactra is a standardised allergen extract from house dust mites Dermatophagoides pteronyssinus and Dermatophagoides farinae. It is indicated for the treatment of house dust mite allergy.
Product Name : Odactra
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 27, 2025
Lead Product(s) : Dermatophagoides Farinae Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Arachis Hypogaea Allergen Extract
Therapeutic Area : Immunology
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Positive Results Advance Peanut Tablet to Phase II Development
Details : ALK Abello AS is developing sublingual immunotherapy (‘SLIT’) tablets and it is under phase 1/2 clinical development for the treatment of Peanut Allergy.
Product Name : Peanut SLIT-tablet
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 18, 2024
Lead Product(s) : Arachis Hypogaea Allergen Extract
Therapeutic Area : Immunology
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : House Dust Mite Allergen Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
ACARIZAX® Approved in Europe for Treatment of Young Children
Details : Acarizax is a standardised allergen extract from house dust mites Dermatophagoides pteronyssinus and Dermatophagoides farinae. It is being indicated for the treatment of house dust mite allergy.
Product Name : Acarizax
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 12, 2024
Lead Product(s) : House Dust Mite Allergen Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Birch Pollen Extract
Therapeutic Area : Immunology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
ALK's European Reg Application for ITULAZAX® for Paediatric Indication Accepted for Review
Details : ITULAZAX is a sublingual immunotherapy tablet of allergen extract for immunotherapy to treat pollen-induced allergic rhinitis and/or conjunctivitis.
Product Name : Itulazax
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 30, 2024
Lead Product(s) : Birch Pollen Extract
Therapeutic Area : Immunology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : House Dust Mite Allergen Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
ALK's Application for House Dust Mite SLIT-Tablet in Children Accepted for Review
Details : Acarizax is a standardised allergen extract from house dust mites Dermatophagoides pteronyssinus and Dermatophagoides farinae, for the treatment of house dust mite allergy.
Product Name : Acarizax
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 25, 2024
Lead Product(s) : House Dust Mite Allergen Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
ALK Completes First Part of Phase 1 Trial with Peanut SLIT-tablet
Details : ALK Abello AS is developing sublingual immunotherapy (‘SLIT’) tablets and it is under phase 1 clinical development for the treatment of Peanut Allergy.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 18, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Birch Pollen Extract
Therapeutic Area : Immunology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : ITULAZAX is a sublingual immunotherapy tablet of allergen extract for immunotherapy of tree (birch homologous group) pollen-induced allergic rhinitis and/or conjunctivitis.
Product Name : Itulazax
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 10, 2023
Lead Product(s) : Birch Pollen Extract
Therapeutic Area : Immunology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : House Dust Mite Allergen Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Odactra (dermatophagoides farinae extract & dermatophagoides pteronyssinus extract) is a prescription medicine used for sublingual immunotherapy to treat house dust mite allergies. ACARIZAX® in Europe and a number of international markets and as MITICUR...
Product Name : Acarizax
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 06, 2023
Lead Product(s) : House Dust Mite Allergen Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : House Dust Mite Allergen Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Regulatory Filing for House Dust Mite Allergy Tablet Accepted for Review in China
Details : Acarizax® (dermatophagoides farinae extract) is an allergy immunotherapy where repeated administration of allergens to allergic individuals is carried to modify the immunological response to allergen to provide sustained protection during subsequent all...
Product Name : Acarizax
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 02, 2023
Lead Product(s) : House Dust Mite Allergen Extract,Dermatophagoides Pteronyssinus Extract
Therapeutic Area : Immunology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable